Vasamed logo

Vasamed(OTC) VSMD

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Vasamed last closing stock price
MetricPriceDate
Last closeUSD 0.002024-10-29
Vasamed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002024-07-23
1 month+0%USD 0.002024-07-23
3 month+0%USD 0.002024-07-23
Year to date+0%USD 0.002023-11-07
1 year+0%USD 0.002023-02-21
3 year-99.9%USD 0.002021-10-18
5 year-100%USD 0.032019-10-31
Since inception-100%USD 84.001996-02-14

Vasamed Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.01M

Net Income (TTM)

-$5.61M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-8.11 (Low)

Price

$0.00

Volume

6,666

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 11, 1999

VSMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vasamed

Vasamed, Inc. is a healthcare company focused on developing and distributing innovative products and services for circulatory health management. Established in 1988, the company is headquartered in Eden Prairie, Minnesota, and offers a range of solutions designed to enhance patient care and clinical outcomes.

Products and Services
  • SensiLase PAD-IQ for measuring skin perfusion pressure
  • Advanced Wound Imaging & SmartDraw systems for precise wound measurement
  • PAD-IQ Studycast for secure transmission of diagnostic results
Growth Outlook
  • Continued demand for circulatory health solutions supports revenue potential
  • Expansion of product offerings enhances market reach and customer base
  • Strategic partnerships may drive innovation and operational efficiency
Financial Highlights
  • Recent quarterly revenue of 513,127 shows growth from previous quarters
  • Operating income margin of 2.41% indicates potential for profitability
  • Current ratio of 0.98 suggests adequate short-term financial health
Vasamed, Inc. specializes in the assessment and management of circulatory health, providing essential tools for clinicians and patients alike. The SensiLase PAD-IQ device stands out as a key offering, enabling accurate measurements critical for patient diagnosis and treatment. The company also emphasizes advanced wound care solutions, which are increasingly important in healthcare settings. The growth outlook for Vasamed appears promising, driven by a rising demand for circulatory health products and the potential for expanding its product line. Strategic partnerships could further enhance innovation and operational capabilities, positioning the company favorably within the healthcare sector. Financially, Vasamed has shown signs of improvement, with a recent quarterly revenue increase and a positive operating income margin. The current ratio indicates that the company is managing its short-term liabilities effectively, which is crucial for sustaining operations and pursuing growth opportunities. Overall, Vasamed, Inc. presents an intriguing option for investors interested in the healthcare industry, particularly in the area of circulatory health management.
AI Generated • Sep 30, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Eden Prairie, MN 55344, US

VSMD Financials

Key Financial Metrics (TTM)

Gross Margin

-5.01%

Operating Margin

342.08%

Net Income Margin

-352.61%

Return on Equity

315.37%

Return on Capital

766.88%

Return on Assets

-305.46%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.01M

Volume

6.67K

Avg. Volume

0

Financials (TTM)

Gross Profit

$367.25K

Operating Income

$4.63M

EBITDA

-$3.67M

Operating Cash Flow

-$4.48M

Capital Expenditure

-$402.97K

Free Cash Flow

-$4.88M

Cash & ST Invst.

$625.41K

Total Debt

$3.01M

Vasamed Performance Analysis

Vasamed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42005-12-3165.9%
Q12006-03-31-20.2%
Q22006-06-301.5%
Q32006-09-3010.7%
Vasamed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42005-12-3138.1%
Q12006-03-31-23.1%
Q22006-06-30-37.5%
Q32006-09-30-2.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2006YOY CHG

Revenue

$513.13K

+48.8%

Gross Profit

$155.79K

+237.4%

Gross Margin

30.36%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

5

N/A

Net Income

-$1.72M

-8.8%

EBITDA

-$795.17K

+48.5%

Quarterly Fundamentals

Name
Q3 2006YOY CHG

Total Cash

$625.41K

-18.9%

Total Debt

$3.01M

+12340.6%

Accounts Receivable

$323.98K

-0.2%

Inventory

$703.21K

+25.9%

Long Term Debt

$3.00M

+15153.7%

Short Term Debt

$6.57K

+46.0%

Return on Assets

-3.05%

N/A

Return on Invested Capital

7.72%

N/A

Free Cash Flow

-$1.31M

+9.0%

Operating Cash Flow

-$1.23M

+13.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GMVDFG Medical Innovations Holdings Ltd
$0.00+0.00%
ASFXAmerican Scientific Resources, Incorporated
$0.00+0.00%
MDITMedite Cancer Diagnostics, Inc.
$0.00+0.00%
MRRCFWayland Group Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
VEEAVeea
$6.09+57.36%
TAT&T
$23.04-6.33%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$34.04+0.74%
SPCXSpace Exploration Technologies
$163.11+1.58%

Questions About VSMD

What is the current price of Vasamed?

Vasamed is trading at $0.00 per share.

What is the 52-week range for Vasamed?

Over the past 52 weeks, Vasamed has traded between $0.00 and $0.00.

How much debt does Vasamed have?

Vasamed total debt is unavailable.

How much cash does Vasamed have on hand?

Vasamed does not have cash on hand data available.

What is Vasamed’s dividend yield?

Vasamed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.